Catheter Precision, Inc.
A medical device company that develops technology for cardiac electrophysiology, including the VIVO system used to help locate the source of abnormal heart rhythms before procedures. The company's tools are used by doctors in hospitals to guide treatment of conditions like ventricular tachycardia. It was formed through a merger of earlier cardiac-mapping ventures and is based in the United States.
Sold 130.0K
Sold 77.6K
Sold 32.5K
Sold 130.8K
Granted 38.1K
Bought 52.3K
Granted 32.9K
Granted 149.3K · Bought 55.3K
Granted 151.5K · Bought 51.0K
Granted 52.4K · Bought 20.0K
Granted 40.5K · Bought 20.0K · Sold 7.8K
Granted 146.3K
Granted 129.0K · Bought 4.4K
Granted 200 · Bought 20.0K · Sold 30.0K
Granted 8.0K
Granted 229.3K · Bought 20.0K · Sold 8.1K
Granted 152.1K · Bought 8.7K · Sold 3
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Burstein Martin +1 co-filer10% owner · 11 transactions | — | 5.27Mas of Dec 2019 | — | — | 130.0K |
| Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 +1 co-filer10% owner, See Remarks, Director, 10% owner · 8 transactions | — | 3.12Mas of Jul 2019 | — | — | 77.6K |
| Irwin Dean10% owner · 6 transactions | — | 3.10Mas of Jan 2020 | — | — | 32.5K |
| Burstein Melissa +2 co-filers10% owner · 3 transactions | — | 2.80Mas of Apr 2020 | — | — | 130.8K |
| Buchbinder MauriceDirector · 2 transactions | — | 70.5Kas of Jun 2019 | 38.1K | — | — |
| Jenkins David AChairman of the Board and CEO · 12 transactions | — | 48.5K | — | 52.3K | — |
| Fogarty Thomas GSee Remarks · 1 transaction | — | 32.9Kas of May 2019 | 32.9K | — | — |
| Enquist William RDirector · 7 transactions | — | 24.0Kas of Jun 2021 | 149.3K | 55.3K | — |
| Mejia Richard JrDirector · 7 transactions | — | 21.9Kas of Jun 2021 | 151.5K | 51.0K | — |
| Horwood DanielGeneral Counsel · 6 transactions | — | 21.9Kas of Nov 2020 | 52.4K | 20.0K | — |
| Jackson Andrew C.CFO · 11 transactions | — | 21.7Kas of May 2022 | 40.5K | 20.0K | 7.8K |
| Saad Mark EDirector · 4 transactions | — | 13.8Kas of Jan 2021 | 146.3K | — | — |
| Stafslien JoanDirector · 4 transactions | — | 13.4Kas of Jun 2021 | 129.0K | 4.4K | — |
| Kraws Jeffrey JCo-President · 7 transactions | — | 5.5Kas of Nov 2020 | 200 | 20.0K | 30.0K |
| Meline SusanneDirector · 3 transactions | — | 3.4Kas of Mar 2023 | 8.0K | — | — |
| McGuire Jonathan WillCEO & Secretary, Director · 10 transactions | — | 1.1Kas of Nov 2022 | 229.3K | 20.0K | 8.1K |
| Colombatto Martin JDirector · 7 transactions | — | 57as of Jan 2025 | 152.1K | 8.7K | 3 |
| Caruso James JosephDirector · 2 transactions | — | 50 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -165.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.